Vaccination against the extra domain-B of fibronectin as a novel tumor therapy

Therapeutic efficacy of a DNA vaccine targeting the endothelial tip cell antigen delta-like ligand 4 in mammary carcinoma

(2010) B K Haller et al.   ONCOGENE

Fibronectins in vascular morphogenesis

(2009) Sophie Astrof et al.   ANGIOGENESIS

Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients

(2009) S. Sauer et al.   BLOOD

Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence

(2009) E Tchougounova et al.   ONCOGENE

Identification of potent biodegradable adjuvants that efficiently break self-tolerance—A key issue in the development of therapeutic vaccines

(2009) Maria Ringvall et al.   VACCINE

Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2

(2008) C. Schliemann et al.   BLOOD

Therapeutic vaccines against IgE-mediated allergies

(2008) Lars Hellman   Expert Review of Vaccines

Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis

(2008) Sofia E. Magnusson et al.   FASEB JOURNAL

Human embryo immune escape mechanisms rediscovered by the tumor

(2008) Laura Ridolfi et al.   IMMUNOBIOLOGY